Search results
Hugh Dudley Auchincloss Jr. (August 15, 1897 – November 20, 1976) was an American stockbroker and lawyer.
Hugh Auchincloss, Jr. (pronounced: aa-kuhn-klaas; born March 15, 1949) is an American immunologist and physician serving as the acting director of the National Institute of Allergy and Infectious Diseases since 2023. He previously served as the principal deputy director between 2006 and 2022.
24 de sept. de 2023 · Dr. Auchincloss oversees NIAID research on HIV/AIDS, infectious diseases, biodefense, and immune-mediated disorders. He is also involved in federal and NIH committees on biocontainment, clinical research, and emergency use authorization.
11 de feb. de 2023 · Dr. Hugh Auchincloss, a transplant surgeon and medical researcher, became the acting director of National Institute for Allergy and Infectious Diseases after Anthony Fauci retired. He faces a challenging role as House Republicans probe the pandemic and the agency's response.
28 de nov. de 2022 · Dr. Hugh Auchincloss. November 28, 2022. This is an oral history with Dr. Hugh Auchincloss, Jr., on November 28, 2022, about his career at the National Institute of Allergy and Infectious Diseases (NIAID). The interview is being done over Zoom, and the interviewer is Dr. Victoria Harden, Founding Director, Emerita, of the Office of ...
20 de ene. de 2023 · Dr. Hugh Auchincloss is the acting director of the National Institute of Allergy and Infectious Diseases (NIAID) since January 2023. He is a transplant surgeon, a former NIAID grantee and a founder of the Juvenile Diabetes Research Foundation Center for Islet Transplantation.
15 de sept. de 2023 · With each new universal influenza vaccine candidate and clinical trial, we take another step closer to that goal,” said Acting NIAID Director Hugh Auchincloss, M.D. The vaccine candidate under investigation, FluMos-v2, was designed by researchers at NIAID’s Vaccine Research Center (VRC).
